This inventor holds 5 USPTO granted patents. Top assignee: Abbott Laboratories Corporation. Active years: 1994-1997.
Company Filing History:
Years Active: 1994-1997
Title: Jeffrey R. Fishpaugh: Innovator in Quantitative Immunoassay Methods
Introduction
Jeffrey R. Fishpaugh, an inventive figure based in Chicago, IL, has made significant contributions to the field of pharmacology and immunoassay technologies. With a commendable portfolio of five patents, his work focuses on the development of reagents and methods for the quantification of critical therapeutic compounds.
Latest Patents
Fishpaugh's latest innovations include two notable patents centered around the quantification of amitriptyline and doxepins. The first patent outlines immunoassay methods and reagents for the specific quantification of amitriptyline and nortriptyline, utilizing antibodies formulated with their respective derivatives. This work not only establishes the synthesis of unique fluorescein tracers but also enhances the specificity and sensitivity of the immunoassays.
The second patent addresses the quantification of total doxepins, including E-doxepin, Z-doxepin, E-desmethyldoxepin, and Z-desmethyldoxepin, via an innovative immunoassay method. This prototype relies on antibodies capable of binding to total doxepins, created using specific immunogens derived from doxepin derivatives. Through these advancements, Fishpaugh significantly contributes to the efficiency and effectiveness of drug monitoring and therapeutic efficacy evaluation.
Career Highlights
Jeffrey R. Fishpaugh works at Abbott Laboratories Corporation, a prestigious organization known for its commitment to advancing healthcare through cutting-edge technology and innovation. His expertise and innovative thinking have positioned him as a key figure in the development of new analytical methods, showcasing a career characterized by a dedication to solving complex problems in pharmaceutical sciences.
Collaborations
Throughout his career, Fishpaugh has collaborated with distinguished colleagues, including Maciej B. Adamczyk and Donald D. Johnson. These collaborations foster a dynamic exchange of ideas and expertise, enhancing the overall quality and impact of their research outcomes. Together, they epitomize the collaborative spirit of scientific research, where innovation thrives through shared knowledge and teamwork.
Conclusion
In summary, Jeffrey R. Fishpaugh stands out as a noteworthy inventor in the realms of immunoassay development and pharmacological analysis. His patents reflect a profound understanding of complex biochemical processes and a commitment to improving drug quantification methodologies. As advancements in pharmaceutical sciences continue to evolve, Fishpaugh's contributions will undoubtedly play a critical role in shaping future innovations in healthcare.